Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
74,190,609
-
Total 13F shares
-
22,488,625
-
Share change
-
-4,533,131
-
Total reported value
-
$23,400,834
-
Price per share
-
$1.04
-
Number of holders
-
60
-
Value change
-
-$4,688,871
-
Number of buys
-
24
-
Number of sells
-
40
Institutional Holders of ENZON PHARMACEUTICALS, INC. - Common Stock, par value $0.01 per share (ENZN) as of Q2 2014
As of 30 Jun 2014,
ENZON PHARMACEUTICALS, INC. - Common Stock, par value $0.01 per share (ENZN) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,488,625 shares.
The largest 10 holders included
ICAHN CARL C, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, BRANDES INVESTMENT PARTNERS, LP, BlackRock Advisors LLC, PRICE MICHAEL F, UBS AG, and GOLDMAN SACHS GROUP INC.
This page lists
60
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.